INCYTE (ICY BE) stock market data APIs
€58.3227
-0.69(-1.2%)
as of May 22, 2025
Try our APIs with
free plan!
INCYTE Financial Data Overview
There is no Profile data available for ICY.BE.
Prev. Close
58.3227
Open
57.6321
High
58.3227
Low
57.5417
52 wk Range
48.23-78.5
Market Cap
12 792 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get INCYTE data using free add-ons & libraries
Get INCYTE Fundamental Data
INCYTE Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-29
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
INCYTE News
New
3 Reasons INCY is Risky and 1 Stock to Buy Instead
Incyte trades at $67 per share and has moved almost in lockstep with the market over the last six months. The stock has lost 6.6% while the S&P 500 is down 2.1%. This may have investors wondering how ...
3 Mid-Cap Stocks with Questionable Fundamentals
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract si...
Incyte Gets FDA Approval for Zynyz in New Cancer Indication
Incyte INCY announced that the FDA has approved its new drug, Zynyz (retifanlimab-dlwr), a PD-1 inhibitor, for treating a new cancer indication. The regulatory body has now approved Zynyz in combinat...
Incyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United States
Zynyz logoLillian Kreppel, Executive Director and Co-Founder of the HPV Cancers Alliance, speaks about the impact of anal cancer on patients and the importance of progress for the communityZynyz packa...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
